New drug JUV-161 tested in healthy volunteers – first step toward muscle disease treatments
Knowledge-focused
Ongoing
This early-stage study is testing a new drug, JUV-161, in 72 healthy adults to see if it is safe and how the body processes it. Participants receive either the drug or a placebo by injection. The study does not aim to treat any disease, but the results will help plan future trial…
Phase: PHASE1 • Sponsor: Juvena Therapeutics • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC